Bio-Thera is dedicated to researching and developing innovative and biosimilar therapeutics for the treatment of cancers, autoimmune, cardiovascular diseases, and other serious medical conditions. Years of hard work have enabled Bio-Thera to develop an impressive range of products, which include innovative monoclonal antibodies and biosimilars. Clinical trials in various phases are already underway for many of our drug candidates, and the progress of these programs is indicated in the table below :